The high court, which was hearing several petitions seeking a ban...
Category:
Non-Life
Latest
India’s universal health insurance plan achievable, says Devi Shetty
Devi Prasad Shetty, Founder and Chairman of Narayana Health This...
FSIB to select CMDs of New India and United India on Mar 20-21, AIC’s Girija S top contender for NIA
This is also for the first time that a serving CMD of a PSU entity...
Brazil’s supreme court rules Covid-19 vaccination can be made mandatory
Bolsonaro has launched an attack on coronavirus vaccines, even suggesting that the one developed by Pfizer-BioNTech could turn people into crocodiles or bearded ladies.
“In the Pfizer contract it’s very clear: ‘we’re not responsible for any side effects.’ If you turn into a crocodile, it’s your problem,” Bolsonaro said on Thursday.That vaccine has been undergoing tests in Brazil for weeks and is already being used in the United States and Britain.
India surpasses somber milestone of 1 cr COVID-19 cases as 25152 infections added; 347 more die
The COVID-19 case fatality rate has further declined to 1.45 per cent.
There are 3,08,751 active cases in the country which constitute 3.08 per cent of the total caseload, the data stated.
Seems third wave of Covid-19 in Delhi brought under control: Kejriwal
The highest single-day spike till date — 8,593 cases — was reported on November 11.
The chief minister said the situation in Delhi has improved significantly as the positivity rate had gone up to 15.26 per cent as in early November.
It is now down to 1.3 per cent, one of the lowest so far in Delhi, and nationally too, he said.
New COVID-19 strain spreads more quickly, UK medical chief says
“As a result of the rapid spread of the new variant, preliminary modelling data and rapidly rising incidence rates in the South East, the New and Emerging Respiratory Virus Threats Advisory Group (NERVTAG) now consider that the new strain can spread more quickly.
Govt must indemnify vaccine makers against all lawsuits: Adar Poonawalla
“We need to have the government indemnify manufacturers, especially vaccine manufacturers, against all lawsuits. In fact, COVAX and other countries have already started talking about that,” Serum Institute of India (SII) Chief Executive Officer Adar Poonawalla . said.
It is because when frivolous claims come up, and something is blown out of proportion in the media, skepticism sets in that definitely something can happen due to the vaccine and to dispel that, the government needs to step in to spread the right information,
He also said that the vaccine makers are going to propose this to the government,
Over 3.9 million people facilitated via Vande Bharat Mission: Hardeep Puri
Taking to Twitter, Puri shared data that showed that on December 18 (Friday) itself 8,546 Indians returned from various locations such as Sharjah, Dubai, London, Toronto, San Francisco, among others.
Is Covid-19 Vaccine a victory for Big Pharma
It’s an incredible public relations coup for an industry desperate to rescue its image. Just last month, Purdue Pharma pleaded guilty and has agreed to penalties of more than $8 billion after being prosecuted for its role in America’s horrific opioid crisis. Pfizer set an earlier record for a drug industry fraud settlement in 2009 at $2.3 billion, in a case over its fraudulent marketing of a painkiller, an antipsychotic and other drugs for conditions for which it hadn’t received approval.The turpitude of the pharmaceutical industry is so commonplace that it has become part of the cultural wallpaper. The screenwriters of the 1993 movie
India at cusp of authorizing 1st set of Covid-19 vax, to cover around 30 cr targeted population: Harsh Vardhan
Observing the fact that despite festivals in October and November, Vardhan said no new surge of cases was observed in this period due to comprehensive testing, tracking and treatment policy implemented on the ground.
The Minister said that India’s Covid-19 pandemic growth has dropped to 2 per cent and the case fatality rate is amongst the lowest in the world at 1.45 per cent.
Insurers, drugmakers sail into unknown with COVID vaccine rollout
Prices for new contracts in the transport insurance market were climbing sharply even before the pandemic following rising claims and reduced competition, and industry sources expect insurance rates to jump when pharma companies involved in COVID-19 vaccines renew their annual policies next year, given the additional risk
Some vaccine doses kept too cold, Pfizer having manufacturing issues, U.S. officials say
Officials are investigating whether storing the vaccines at excessively cold temperatures poses a safety or efficacy risk, he said.